Classic Hodgkin Lymphoma: A Review

JAMA published a comprehensive review summarizing current evidence on the pathogenesis, epidemiology, diagnosis, and management of classic Hodgkin lymphoma in adults aged 18 years and older. The article synthesizes the evolving treatment landscape, including risk-adapted therapy and newer agents, within the context of established clinical practice. It serves as a reference consolidation rather than presenting novel trial data or practice-changing findings.